Last edition
News about "SEBI regulations"
Cipla's Bommasandra Facility Gets VAI Classification from USFDA
Cipla has announced that its manufacturing facility in Bommasandra, Bengaluru, has received a Voluntary Action Indicated (VAI) classification from the USFDA following a recent inspection.
SEBI Regulations | 06/08/2025 | By Dineshwori | 203
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members